Not having read the article, I'll give my take on the question:
Ivermectin and vitamin D3 are a bridge to immunization.
Everyone, both known high and low risk folks, should be sure their vitamin D nutrition is good (4000-6000 IU per day).
It will not be long before those with highest risk have all received their first one or two vaccination shots (against the original strain). Until that is accomplished those still awaiting the vaccine should probably be doing prophylactic ivermectin. We want to minimize the number taking ivermetin, so that the virus does not develop resistance to the drug.
For lower risk people, ivermectin should be started at the time the diagnosis is confirmed, assuming rapid testing is readily available. If there will be more than a day or two delay for test results, ivermectin should be started at the onset of definite symptoms.
Once vaccination is accomplished, the risk of hospitalization or ICU admission is very low, at least until we know more about newly emerging strains, which may require a booster with the new mRNA structure, so ivermectin will not be much needed.
[-] lemallette | 2 points | Feb 26 2021 22:12:58
Not having read the article, I'll give my take on the question:
Ivermectin and vitamin D3 are a bridge to immunization.
Everyone, both known high and low risk folks, should be sure their vitamin D nutrition is good (4000-6000 IU per day).
It will not be long before those with highest risk have all received their first one or two vaccination shots (against the original strain). Until that is accomplished those still awaiting the vaccine should probably be doing prophylactic ivermectin. We want to minimize the number taking ivermetin, so that the virus does not develop resistance to the drug.
For lower risk people, ivermectin should be started at the time the diagnosis is confirmed, assuming rapid testing is readily available. If there will be more than a day or two delay for test results, ivermectin should be started at the onset of definite symptoms.
Once vaccination is accomplished, the risk of hospitalization or ICU admission is very low, at least until we know more about newly emerging strains, which may require a booster with the new mRNA structure, so ivermectin will not be much needed.
permalink